WHO Adds Rare Disease Treatments to the Essential Medicines List
Salome Mekhuzla, Director of Global Development at the World Federation of Hemophilia, reposted from Rare Diseases International on LinkedIn:
”Thrilled to have contributed to this project and congratulations to RDI team on all the work accomplished.”
Quoting Rare Diseases International‘s post:
”New Report Published!
With the publication of the updated WHO Model List of Essential Medicines (EML) and the Model List for Children (EMLc), important progress has been made: for the first time, treatments for several rare diseases have been included. This achievement highlights how advocacy and active engagement are vital to ensure that more therapies for rare diseases are recognized as essential in the future. In this context, RDI is proud to share the publication of the Essential Medicines Working Group (EMWG) Report.
This report, developed by RDI’s Essential Medicines Working Group, explores:
- Successful and unsuccessful applications for rare disease medicines to the EML, identifying challenges, success factors, and opportunities to strengthen the evaluation process for essential RD medicines.
- Concrete recommendations and a Call-to-Action to strengthen the EML’s impact for people living with rare diseases globally.
This work would not have been possible without the invaluable contributions of the members of the RDI Essential Medicines Working Group and the organizations that generously shared their experiences. Special thanks to all contributors for their dedication and insights. This project was developed by RDI Global Programme: Chiuhui Mary Wang, Chiara Tovani and Sara Brambilla.
Read the full report here․
For more information, check our website․”
Stay updated with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia